EDIT:NASDAQ
Editas Medicine Inc
2,17 USD
0,00%
(0,00) 1D
2,18 USD
arrow_upward
+0,46% (+0,0100)todayPrije radnog vremena
Zatvoreno: 13. stu, 16:00:01 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Trž. kap.
334,92 mil.
Prosj. kol.
2,44 mil.
Količina
4,85 tis.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Trž. kap.
334,92 mil.
Prosj. kol.
2,44 mil.
Količina
4,85 tis.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
www.marketscreener.com
·
prije 19 minuta
Alexandria Real Estate Equities, Inc. Announces Dual Listing on NYSE Texas, Reinforcing Its Strategic Commitment to Texas
Investing.com
·
prije 32 minute
MediWound’s CEO and Chairman Increase Their Holdings as a Pivotal Trial Milestone Nears (NASDAQ: MDWD)
Foreign Policy Journal
·
prije 15 minuta
10-Year Treasury Yield Hits 4-Week High As Semiconductor Stocks Drag NASDAQ: QQQ, NASDAQ: SOXX, and (NASDAQ: AMD) Lower
The Washington Post
·
prije 53 minute
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com